An off-the-shelf help list: A comprehensive catalog of preference scores from published cost-utility analyses

Medical Decision Making

Volumn 21, Issue 4, 2001, Pages 288-294

  Bell, Chaim M ^a,b   Chapman, Richard H ^a   Stone, Patricia W ^a,c   Sandberg, Eileen A ^a   Neumann, Peter J ^a  

^a HARVARD CENTER FOR RISK ANALYSIS   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF ROCHESTER SCHOOL OF NURSING   (United States)

Author keywords

Cost utility analysis; Health states; Preferences; Quality of life; Quality adjusted life year (QALY); Utility

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DATA BASE; HEALTH CARE COST; INTERNET; MEDICAL INFORMATION; PUBLICATION; QUALITY ADJUSTED LIFE YEAR; SCORING SYSTEM;

CONSUMER SATISFACTION; COST-BENEFIT ANALYSIS; DATA COLLECTION; DECISION MAKING; DISEASE; HEALTH SERVICES RESEARCH; HUMANS; QUALITY-ADJUSTED LIFE YEARS; VALUE OF LIFE;

EID: 0034941084     PISSN: 0272989X     EISSN: None     Source Type: Journal    
DOI: 10.1177/02729890122062587     Document Type: Article

References (30)

1. The quality of reporting in published cost-utility analyses 1976-1997
2. Modelling the cost effectiveness of antidepressant treatment in primary care
3. Cost-utility in practice: A policy maker's guide to the state of the art
4. Towards quality assurance in QALY calculations
5. Reporting guidelines for economic studies
6. Raising the quality of cost-utility analyses: Lessons learnt and still to learn
7. Are the methods for estimating QALYs in cost-effectiveness analysis improving?
8. One thousand health-related quality-of-life estimates
9. The Beaver Dam Health Outcomes Study: Initial catalog of health-state quality factors
10. Variability among methods to assess patients' well-being and consequent effect on a cost-effectiveness analysis
11. Health related quality of life in economic evaluations for osteoporosis: Whose values should we use?
12. Preferences for health outcomes: Comparisons of assessment methods
13. Methods for quality adjustment of life years
14. Variation in patient utilities for outcomes of the management of chronic stable angina: Implications for clinical practice guidelines
15. Cost-effectiveness of laparoscopic versus open cholecystectomy
16. Foot infections in diabetic patients: Decision and cost-effectiveness analysis
17. An economic evaluation of finasteride for treatment of benign prostatic hyperplasia
18. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017
19. Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease: Use of a decision-analytic model
20. Cost-effectiveness of extracorporeal shock-wave lithotripsy versus cholecystectomy for symptomatic gallstones
21. Incorporating future costs in medical cost-effectiveness analysis: Implications for the cost-effectiveness of the treatment of hypertension
22. An economic analysis of the Survival and Ventricular Enlargement (SAVE) Study: Applications to the United Kingdom
23. The decision concerning coronary angiography in patients with chest pain: A cost-effectiveness analysis
24. A comparison of accelerated tissue plasminogen activator with streptokinase for treatment of suspected myocardial infarction
25. Cost-effectiveness of screening for carotid stenosis in asymptomatic persons
26. A comparison of HUI2 and HUI3 utility scores in Alzheimer's disease